Literature DB >> 18239321

Longitudinal analysis of cytokines and chemokines in the cerebrospinal fluid of a patient with Neuro-Sweet disease presenting with recurrent encephalomeningitis.

Akio Kimura1, Takeo Sakurai, Akihiro Koumura, Yoshihiro Suzuki, Yuji Tanaka, Isao Hozumi, Hideto Nakajima, Takashi Ichiyama, Takashi Inuzuka.   

Abstract

BACKGROUND: Neuro-Sweet disease (NSD) has recently been identified as Sweet disease with central nervous system (CNS) involvement characterized by multisystem neutrophilic infiltration. However, the pathogenesis of this disease remains unknown. Neutrophil and other inflammatory cell activities are influenced by many cytokines and chemokines, but to date, no studies have examined the levels of these factors in patients with NSD. PATIENT AND METHODS: The patient presented with encephalomeningitis twice in one year and was diagnosed with NSD. We measured the levels of cytokines (i.e., IL-2, IL-4, IL-6, IL-10, IFN-gamma, and TNF-alpha) and chemokines (i.e., CCL2, CCL3, CCL5, CXCL8, CXCL10 and GM-CSF) in 10 CSF samples from the patient longitudinally for one year including those during two episodes of encephalomeningitis.
RESULTS: The elevations of IL-6, IFN-gamma, CXCL8 (IL8) and CXCL10 (IP10) were markedly higher than the levels in uninfected control subjects with neurological disorders. The levels of these cytokines and chemokines were statistically correlated with total CSF cell counts (p <0.01).
CONCLUSION: CD4+ helper T (Th) cells can be divided into the Th1 and Th2 subtypes according to their cytokine secretion patterns, and IFN-gamma and IP10 are the Th1-type cytokine and chemokine indicating the involvement of Th1 cells in NSD. In addition, the level of IL8, a specific neutrophil chemoattractant, correlated well with the neutrophil cell counts in CSF. Our data suggest the important roles of Th1 cells and IL8 in the pathogenesis of NSD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239321     DOI: 10.2169/internalmedicine.47.0370

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Successful treatment for sympathetic storms in a patient with neuro-Behçet's disease.

Authors:  Takahisa Gono; Megumi Murata; Yasushi Kawaguchi; Daisuke Wakasugi; Makoto Soejima; Hisashi Yamanaka; Masako Hara
Journal:  Clin Rheumatol       Date:  2008-12-20       Impact factor: 2.980

2.  Two cases of possible neuro-Sweet disease with meningoencephalitis as the initial manifestation.

Authors:  Go Makimoto; Yasuhiro Manabe; Chizuru Yamakawa; Daiki Fujii; Yasuko Ikeda-Sakai; Hisashi Narai; Nobuhiko Omori; Koji Abe
Journal:  Neurol Int       Date:  2012-02-09

Review 3.  Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.

Authors:  Helen Ha; Bikash Debnath; Nouri Neamati
Journal:  Theranostics       Date:  2017-04-07       Impact factor: 11.556

4.  Increase of a wide range of bioactive substances in an active phase of neuro-Sweet disease.

Authors:  Hiroi Kusaka; Katsuya Nagatani; Takeo Sato; Seiji Minota
Journal:  BMJ Case Rep       Date:  2020-04-08

5.  Neuro-Behçet Disease, Neuro-Sweet Disease, and Spectrum Disorders.

Authors:  Kinya Hisanaga
Journal:  Intern Med       Date:  2021-10-05       Impact factor: 1.271

6.  Neuro-Sweet disease with positive modified acid-fast staining of the cerebrospinal fluid: A case report.

Authors:  Juan-Fang Liu; Yuan Li; Kai Li; Xiao Zhang; Yi-Ning Yang; Gang Zhao; Zhi-Rong Liu
Journal:  Exp Ther Med       Date:  2016-02-08       Impact factor: 2.447

7.  T-cell Lymphoma Presenting Neutrophilic Inflammation in the Cerebrospinal Fluid.

Authors:  Takaaki Nakamura; Yoshiki Takai; Kimihiko Kaneko; Hiroshi Kuroda; Tatsuro Misu; Kiyotaka Asanuma; Ryoko Saito; Masashi Aoki
Journal:  Intern Med       Date:  2019-10-07       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.